Application 076161
- Type
- ANDA
- Sponsor
- DAVA PHARMS INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DOXAZOSIN MESYLATE | DOXAZOSIN MESYLATE | TABLET;ORAL | EQ 1MG BASE | No | No |
| 002 | DOXAZOSIN MESYLATE | DOXAZOSIN MESYLATE | TABLET;ORAL | EQ 2MG BASE | No | No |
| 003 | DOXAZOSIN MESYLATE | DOXAZOSIN MESYLATE | TABLET;ORAL | EQ 4MG BASE | No | No |
| 004 | DOXAZOSIN MESYLATE | DOXAZOSIN MESYLATE | TABLET;ORAL | EQ 8MG BASE | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A076161-001 | DOXAZOSIN MESYLATE | DOXAZOSIN MESYLATE | EQ 1MG BASE | TABLET / ORAL | 2004-06-10 | ||
| A076161-002 | DOXAZOSIN MESYLATE | DOXAZOSIN MESYLATE | EQ 2MG BASE | TABLET / ORAL | 2004-06-10 | ||
| A076161-003 | DOXAZOSIN MESYLATE | DOXAZOSIN MESYLATE | EQ 4MG BASE | TABLET / ORAL | 2004-06-10 | ||
| A076161-004 | DOXAZOSIN MESYLATE | DOXAZOSIN MESYLATE | EQ 8MG BASE | TABLET / ORAL | 2004-06-10 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A076161-001 | DOXAZOSIN MESYLATE | EQ 1MG BASE | TABLET / ORAL | 2004-06-10 | 6a51e52b5d6a… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A076161-002 | DOXAZOSIN MESYLATE | EQ 2MG BASE | TABLET / ORAL | 2004-06-10 | 6a51e52b5d6a… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A076161-003 | DOXAZOSIN MESYLATE | EQ 4MG BASE | TABLET / ORAL | 2004-06-10 | 6a51e52b5d6a… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A076161-004 | DOXAZOSIN MESYLATE | EQ 8MG BASE | TABLET / ORAL | 2004-06-10 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A076161-001 | DOXAZOSIN MESYLATE | EQ 1MG BASE | TABLET / ORAL | 2004-06-10 | 1c564ffb4f44… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A076161-002 | DOXAZOSIN MESYLATE | EQ 2MG BASE | TABLET / ORAL | 2004-06-10 | 1c564ffb4f44… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A076161-003 | DOXAZOSIN MESYLATE | EQ 4MG BASE | TABLET / ORAL | 2004-06-10 | 1c564ffb4f44… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A076161-004 | DOXAZOSIN MESYLATE | EQ 8MG BASE | TABLET / ORAL | 2004-06-10 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A076161-001 | DOXAZOSIN MESYLATE | EQ 1MG BASE | TABLET / ORAL | 2004-06-10 | ea1830bbd6c7… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A076161-002 | DOXAZOSIN MESYLATE | EQ 2MG BASE | TABLET / ORAL | 2004-06-10 | ea1830bbd6c7… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A076161-003 | DOXAZOSIN MESYLATE | EQ 4MG BASE | TABLET / ORAL | 2004-06-10 | ea1830bbd6c7… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A076161-004 | DOXAZOSIN MESYLATE | EQ 8MG BASE | TABLET / ORAL | 2004-06-10 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A076161-001 | DOXAZOSIN MESYLATE | EQ 1MG BASE | TABLET / ORAL | 2004-06-10 | a72a2bbeb626… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A076161-002 | DOXAZOSIN MESYLATE | EQ 2MG BASE | TABLET / ORAL | 2004-06-10 | a72a2bbeb626… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A076161-003 | DOXAZOSIN MESYLATE | EQ 4MG BASE | TABLET / ORAL | 2004-06-10 | a72a2bbeb626… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A076161-004 | DOXAZOSIN MESYLATE | EQ 8MG BASE | TABLET / ORAL | 2004-06-10 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A076161-001 | DOXAZOSIN MESYLATE | EQ 1MG BASE | TABLET / ORAL | 2004-06-10 | 9b2671bbb829… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A076161-002 | DOXAZOSIN MESYLATE | EQ 2MG BASE | TABLET / ORAL | 2004-06-10 | 9b2671bbb829… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A076161-003 | DOXAZOSIN MESYLATE | EQ 4MG BASE | TABLET / ORAL | 2004-06-10 | 9b2671bbb829… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A076161-004 | DOXAZOSIN MESYLATE | EQ 8MG BASE | TABLET / ORAL | 2004-06-10 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A076161-001 | DOXAZOSIN MESYLATE | EQ 1MG BASE | TABLET / ORAL | 2004-06-10 | a67488948f0b… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A076161-002 | DOXAZOSIN MESYLATE | EQ 2MG BASE | TABLET / ORAL | 2004-06-10 | a67488948f0b… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A076161-003 | DOXAZOSIN MESYLATE | EQ 4MG BASE | TABLET / ORAL | 2004-06-10 | a67488948f0b… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A076161-004 | DOXAZOSIN MESYLATE | EQ 8MG BASE | TABLET / ORAL | 2004-06-10 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A076161-001 | DOXAZOSIN MESYLATE | EQ 1MG BASE | TABLET / ORAL | 2004-06-10 | 3f0d92c62455… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A076161-002 | DOXAZOSIN MESYLATE | EQ 2MG BASE | TABLET / ORAL | 2004-06-10 | 3f0d92c62455… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A076161-003 | DOXAZOSIN MESYLATE | EQ 4MG BASE | TABLET / ORAL | 2004-06-10 | 3f0d92c62455… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A076161-004 | DOXAZOSIN MESYLATE | EQ 8MG BASE | TABLET / ORAL | 2004-06-10 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A076161-001 | DOXAZOSIN MESYLATE | EQ 1MG BASE | TABLET / ORAL | 2004-06-10 | 053a50430f4f… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A076161-002 | DOXAZOSIN MESYLATE | EQ 2MG BASE | TABLET / ORAL | 2004-06-10 | 053a50430f4f… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A076161-003 | DOXAZOSIN MESYLATE | EQ 4MG BASE | TABLET / ORAL | 2004-06-10 | 053a50430f4f… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A076161-004 | DOXAZOSIN MESYLATE | EQ 8MG BASE | TABLET / ORAL | 2004-06-10 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A076161-001 | DOXAZOSIN MESYLATE | EQ 1MG BASE | TABLET / ORAL | 2004-06-10 | 3bdfa0b2c4d7… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A076161-002 | DOXAZOSIN MESYLATE | EQ 2MG BASE | TABLET / ORAL | 2004-06-10 | 3bdfa0b2c4d7… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A076161-003 | DOXAZOSIN MESYLATE | EQ 4MG BASE | TABLET / ORAL | 2004-06-10 | 3bdfa0b2c4d7… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A076161-004 | DOXAZOSIN MESYLATE | EQ 8MG BASE | TABLET / ORAL | 2004-06-10 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A076161-001 | DOXAZOSIN MESYLATE | EQ 1MG BASE | TABLET / ORAL | 2004-06-10 | 3a93d1ddd44b… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A076161-002 | DOXAZOSIN MESYLATE | EQ 2MG BASE | TABLET / ORAL | 2004-06-10 | 3a93d1ddd44b… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A076161-003 | DOXAZOSIN MESYLATE | EQ 4MG BASE | TABLET / ORAL | 2004-06-10 | 3a93d1ddd44b… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A076161-004 | DOXAZOSIN MESYLATE | EQ 8MG BASE | TABLET / ORAL | 2004-06-10 | 3a93d1ddd44b… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A076161-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A076161-002 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A076161-003 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A076161-004 | AB | 1 | 74a2ff9319b5… |
| 2019-12-14 00:12 UTC | 2019-12 | A076161-001 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A076161-002 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A076161-003 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A076161-004 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A076161-001 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A076161-002 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A076161-003 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A076161-004 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A076161-001 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A076161-002 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A076161-003 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A076161-004 | AB | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Doxazosin | DOXAZOSIN MESYLATE | Bryant Ranch Prepack | 277c3278-4fe2-47ac-9115-15b417325ffd | 2026-04-13 | Warnings, Adverse reactions | DOXAZOSIN MESYLATE |
| Doxazosin | DOXAZOSIN MESYLATE | Bryant Ranch Prepack | e2f5d7d2-21aa-4921-8035-da945d3c565c | 2026-03-04 | Warnings, Adverse reactions | DOXAZOSIN MESYLATE |
| Doxazosin | DOXAZOSIN MESYLATE | Bryant Ranch Prepack | 8641cdb1-dc16-4a13-8a84-bc8f6d58b4d4 | 2026-02-13 | Warnings, Adverse reactions | DOXAZOSIN MESYLATE |
| Doxazosin | DOXAZOSIN MESYLATE | Northwind Health Company, LLC | f6c9856e-9154-f349-e053-6294a90a9f2c | 2026-01-19 | Warnings, Adverse reactions | DOXAZOSIN MESYLATE |
| Doxazosin | DOXAZOSIN MESYLATE | A-S Medication Solutions | 7aeaa0e1-136c-444d-b66c-7a5a96fb3022 | 2025-12-05 | Warnings, Adverse reactions | DOXAZOSIN MESYLATE |
| Doxazosin mesylate | DOXAZOSIN MESYLATE | Aphena Pharma Solutions - Tennessee, LLC | 445dc831-1960-4b25-e063-6294a90a6efd | 2025-11-24 | Warnings, Adverse reactions | Doxazosin mesylate DOXAZOSIN MESYLATE |
| Doxazosin | DOXAZOSIN MESYLATE | Upsher-Smith laboratories, LLC | b5d1c604-ce3b-4973-845f-9db267a945cd | 2025-11-12 | Warnings, Adverse reactions | DOXAZOSIN MESYLATE |
| Doxazosin | DOXAZOSIN MESYLATE | Bryant Ranch Prepack | d42d2691-f25d-4dfc-99d0-3286d71480a4 | 2025-10-13 | Warnings, Adverse reactions | DOXAZOSIN MESYLATE |
| Doxazosin | DOXAZOSIN MESYLATE | A-S Medication Solutions | 57f4a953-ad23-4a44-9956-c48aa5927132 | 2025-10-02 | Warnings, Adverse reactions | DOXAZOSIN MESYLATE |
| Doxazosin | DOXAZOSIN MESYLATE | A-S Medication Solutions | b4c974ad-cbd6-4811-ab48-461e7ffa99f7 | 2025-09-17 | Warnings, Adverse reactions | DOXAZOSIN MESYLATE |
| Doxazosin | DOXAZOSIN MESYLATE | A-S Medication Solutions | 9b6170e7-814a-46ef-b068-cf3e6508d5e1 | 2024-10-21 | Warnings, Adverse reactions | DOXAZOSIN MESYLATE |
| Doxazosin | DOXAZOSIN MESYLATE | Aurobindo Pharma Limited | 93f2d724-5a54-4721-b04a-e46bc764607b | 2024-09-06 | Warnings, Adverse reactions | DOXAZOSIN MESYLATE |
| Doxazosin mesylate | DOXAZOSIN MESYLATE | Mylan Pharmaceuticals Inc. | 2e524986-7903-416f-b2b8-d27295103e75 | 2024-03-11 | Warnings, Adverse reactions | Doxazosin mesylate DOXAZOSIN MESYLATE |
| Doxazosin | DOXAZOSIN MESYLATE | Aphena Pharma Solutions - Tennessee, LLC | 0d9df8e9-f823-4ff8-a5fe-0309dd132b04 | 2024-02-06 | Warnings, Adverse reactions | DOXAZOSIN MESYLATE |
| Doxazosin Mesylate | DOXAZOSIN MESYLATE | Unichem Pharmaceuticals (USA), Inc. | 44bfe5d7-a56a-46f1-8ef3-ad386ab35f0f | 2024-01-23 | Warnings, Adverse reactions | Doxazosin Mesylate DOXAZOSIN MESYLATE |
| Doxazosin mesylate | DOXAZOSIN MESYLATE | Chartwell RX, LLC | a7f589b0-eebb-48cb-912f-a4bd956e4dcb | 2023-06-09 | Warnings, Adverse reactions | Doxazosin mesylate DOXAZOSIN MESYLATE |
| Cardura XL | DOXAZOSIN MESYLATE | Viatris Specialty LLC | 355bcdce-0481-48ba-8ebd-2009106aaf77 | 2023-05-15 | Warnings, Adverse reactions | DOXAZOSIN MESYLATE |
| Doxazosin | DOXAZOSIN MESYLATE | Teva Pharmaceuticals USA, Inc. | 0aaa68a7-f73b-46d8-860f-a76d96897489 | 2021-11-30 | Warnings, Adverse reactions | DOXAZOSIN MESYLATE |
| Doxazosin | DOXAZOSIN MESYLATE | Aphena Pharma Solutions - Tennessee, LLC | 6b74b18f-b89a-4109-a29e-c4fa65a3c5ee | 2020-12-10 | Warnings, Adverse reactions | DOXAZOSIN MESYLATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 10544-292 | Doxazosin Mesylate | Doxazosin Mesylate | Blenheim Pharmacal, Inc. | ANDA | Current |
| 10544-629 | Doxazosin Mesylate | Doxazosin Mesylate | Blenheim Pharmacal, Inc. | ANDA | Current |
| 43353-646 | Doxazosin Mesylate | Doxazosin Mesylate | Aphena Pharma Solutions - Tennessee, LLC | ANDA | Current |
| 43353-739 | Doxazosin Mesylate | Doxazosin Mesylate | Aphena Pharma Solutions - Tennessee, LLC | ANDA | Current |
| 43353-740 | Doxazosin Mesylate | Doxazosin Mesylate | Aphena Pharma Solutions - Tennessee, LLC | ANDA | Current |
| 50090-0735 | Doxazosin Mesylate | Doxazosin Mesylate | A-S Medication Solutions | ANDA | Current |
| 50090-1591 | Doxazosin Mesylate | Doxazosin Mesylate | A-S Medication Solutions | ANDA | Current |
| 53808-1017 | Doxazosin mesylate | doxazosin mesylate | State of Florida DOH Central Pharmacy | ANDA | Current |
| 53808-1107 | Doxazosin Mesylate | Doxazosin Mesylate | DOH CENTRAL PHARMACY | ANDA | Current |
| 60429-953 | Doxazosin Mesylate | Doxazosin Mesylate | Golden State Medical Supply, Inc. | ANDA | Current |
| 60429-953 | Doxazosin Mesylate | Doxazosin Mesylate | Golden State Medical Supply, Inc. | ANDA | Current |
| 60429-954 | Doxazosin Mesylate | Doxazosin Mesylate | Golden State Medical Supply, Inc. | ANDA | Current |
| 60429-954 | Doxazosin Mesylate | Doxazosin Mesylate | Golden State Medical Supply, Inc. | ANDA | Current |
| 60429-955 | Doxazosin Mesylate | Doxazosin Mesylate | Golden State Medical Supply, Inc. | ANDA | Current |
| 60429-955 | Doxazosin Mesylate | Doxazosin Mesylate | Golden State Medical Supply, Inc. | ANDA | Current |
| 60429-956 | Doxazosin Mesylate | Doxazosin Mesylate | Golden State Medical Supply, Inc. | ANDA | Current |
| 60429-956 | Doxazosin Mesylate | Doxazosin Mesylate | Golden State Medical Supply, Inc. | ANDA | Current |
| 67253-380 | Doxazosin Mesylate | Doxazosin Mesylate | Par Pharmaceutical | ANDA | Current |
| 67253-380 | Doxazosin Mesylate | Doxazosin Mesylate | Par Pharmaceutical | ANDA | Current |
| 67253-381 | Doxazosin Mesylate | Doxazosin Mesylate | Par Pharmaceutical | ANDA | Current |
| 67253-381 | Doxazosin Mesylate | Doxazosin Mesylate | Par Pharmaceutical | ANDA | Current |
| 67253-382 | Doxazosin Mesylate | Doxazosin Mesylate | Par Pharmaceutical | ANDA | Current |
| 67253-382 | Doxazosin Mesylate | Doxazosin Mesylate | Par Pharmaceutical | ANDA | Current |
| 67253-383 | Doxazosin Mesylate | Doxazosin Mesylate | Par Pharmaceutical | ANDA | Current |
| 67253-383 | Doxazosin Mesylate | Doxazosin Mesylate | Par Pharmaceutical | ANDA | Current |
| 68258-6099 | Doxazosin Mesylate | Doxazosin Mesylate | Dispensing Solutions, Inc. | ANDA | Current |
| 70518-0184 | Doxazosin Mesylate | Doxazosin Mesylate | REMEDYREPACK INC. | ANDA | Current |